Back

Natriuretic peptide receptor 1 targeting chimeras for cardiovascular selective degradation of extracellular proteins

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure frontiers: from decongestion to advanced therapeutics Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kaiyue Zhang

Wuhan (China)

7 More presentations in this session

Presentation thumbnail
Multicenter machine learning based risk assessment model, integrating omics, clinical and patient centred data to prevent recurrent heart failure events
Professor J. Comin-Colet (Barcelona, ES)
Abstract
Presentation thumbnail
Preemptive cardiorenal phenotyping to forecast diuretic resistance in acute heart failure: derivation and internal validation of the strides score
Doctor H. Al Farhan (Baghdad, IQ)
Abstract
Presentation thumbnail
Benefits of sotagliflozin across the full range of baseline blood pressure in the SOLOIST-WHF Trial
Doctor E. Zitelny (New York City, US)
Abstract
Presentation thumbnail
Pre-event guideline-directed optimized medical therapy intensity and in-hospital mortality in heart failure–related cardiogenic shock: insights from the ALT-SHOCK registry
Doctor G. Guarnieri (Milan, IT)
Abstract
Presentation thumbnail
The ACETAZ-HF trial: intravenous furosemide plus oral acetazolamide for rapid decongestion in acute HFrEF and sustained outpatient benefit
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract

Access the full session

Session thumbnail
Heart failure frontiers: from decongestion to advanced therapeutics

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Atrial natriuretic peptide conjugated spermine-acetalated dextran nanoparticles for targeted miRNA delivery to the heart
21 May 2023
thumbnail
Congress Presentation
Comparison of N-terminal pro-brain natriuretic peptide and soluble interleukin-1 receptor-like 1 in predicting prognosis of patients with hypertrophic cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis
27 August 2021
thumbnail
Congress Presentation
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources